NCT03622983 Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization
| NCT ID | NCT03622983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Intercommunal Creteil |
| Condition | Pelvic Neoplasms |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2017-05-01 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2017-05-01 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The management of pelvic gynecological cancers (PGC) is based on the determination of extension to guide treatments. The biology of the CGP is constantly evolving and personalized medicine adapted to this biology is currently in full development. For example, sequencing ovarian tumors can select patients who can benefit from anti-PARP therapy. There is therefore a need for patients to have biological samples of their tumor. Various studies on ovarian, endometrial and cervical cancer have sought to identify the factors predictive of recurrence of these cancers. The results obtained are very promising. This study will permit to collect biological samples and detailed clinical data that would allow to test hypotheses and develop a personalized medicine based on clinical and biological characteristics of patients.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of pelvic gynecological cancer posed on initial histological analysis or during recurrence; * Or diagnosis of endometriosis on histology or imaging * Age ≥ 18 years; * Affiliation to the general social security scheme; * Consent signed. Exclusion Criteria: * Refusal of the patient; * Non-affiliation to the general social security scheme.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03622983 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Pelvic Neoplasms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03622983 currently recruiting?
Yes, NCT03622983 is actively recruiting participants. Contact the research team at cyril.touboul@gmail.com for enrollment information.
Where is the NCT03622983 trial being conducted?
This trial is being conducted at Créteil, France, Paris, France.
Who is sponsoring the NCT03622983 clinical trial?
NCT03622983 is sponsored by Centre Hospitalier Intercommunal Creteil. The trial plans to enroll 500 participants.